PL2425814T3 - Emulsja typu woda-w-oleju do leczenia choroby oka - Google Patents

Emulsja typu woda-w-oleju do leczenia choroby oka

Info

Publication number
PL2425814T3
PL2425814T3 PL10175337T PL10175337T PL2425814T3 PL 2425814 T3 PL2425814 T3 PL 2425814T3 PL 10175337 T PL10175337 T PL 10175337T PL 10175337 T PL10175337 T PL 10175337T PL 2425814 T3 PL2425814 T3 PL 2425814T3
Authority
PL
Poland
Prior art keywords
eye
disease
treating
water
oil type
Prior art date
Application number
PL10175337T
Other languages
English (en)
Inventor
Frédéric Lallemand
Jean-Sébastien Garrigue
Original Assignee
Santen Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Sas filed Critical Santen Sas
Publication of PL2425814T3 publication Critical patent/PL2425814T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL10175337T 2010-09-03 2010-09-03 Emulsja typu woda-w-oleju do leczenia choroby oka PL2425814T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10175337.4A EP2425814B1 (en) 2010-09-03 2010-09-03 A water-in-oil type emulsion for treating a disease of the eye

Publications (1)

Publication Number Publication Date
PL2425814T3 true PL2425814T3 (pl) 2013-11-29

Family

ID=43662067

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10175337T PL2425814T3 (pl) 2010-09-03 2010-09-03 Emulsja typu woda-w-oleju do leczenia choroby oka

Country Status (10)

Country Link
EP (1) EP2425814B1 (pl)
CY (1) CY1114688T1 (pl)
DK (1) DK2425814T3 (pl)
ES (1) ES2426603T3 (pl)
HR (1) HRP20130830T1 (pl)
PL (1) PL2425814T3 (pl)
PT (1) PT2425814E (pl)
SI (1) SI2425814T1 (pl)
SM (1) SMT201300101B (pl)
UA (1) UA111168C2 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10131910B2 (en) 2014-07-10 2018-11-20 Stichting Katholieke Universiteit Antisense oligonucleotides for the treatment of Usher syndrome type 2
GB201503408D0 (en) 2015-02-27 2015-04-15 Proqr Therapeutics N V Oligonucleotides
AU2016335032B2 (en) 2015-10-05 2022-04-14 Proqr Therapeutics Ii B.V. Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion
CN109125261B (zh) * 2016-03-16 2021-11-30 苏州澳宗生物科技有限公司 依达拉奉剂型
CN109310632A (zh) * 2016-04-12 2019-02-05 封装技术私人有限公司 用于递送生物活性剂的可注射组合物
MX2018013003A (es) 2016-04-25 2019-01-28 Proqr Therapeutics Ii Bv Oligonucleotidos para tratar una enfermedad ocular.
GB201616202D0 (en) 2016-09-23 2016-11-09 Proqr Therapeutics Ii Bv Antisense oligonucleotides for the treatment of eye deisease
WO2018109011A1 (en) 2016-12-13 2018-06-21 Stichting Katholieke Universiteit Antisense oligonucleotides for the treatment of stargardt disease
GB201706009D0 (en) 2017-04-13 2017-05-31 Proqr Therapeutics Ii Bv Antisense oligonucleotides for the treatment of stargardt disease
WO2020015959A1 (en) 2018-07-19 2020-01-23 Stichting Katholieke Universiteit Antisense oligonucleotides rescue aberrant splicing of abca4.
JP2022510673A (ja) 2018-12-04 2022-01-27 スティッチング カソリーケ ウニベルシテイト アンチセンスオリゴヌクレオチドは、ａｂｃａ４の異常スプライシングをレスキューする
WO2020157014A1 (en) 2019-01-28 2020-08-06 Proqr Therapeutics Ii B.V. Antisense oligonucleotides for the treatment of leber's congenital amaurosis
US20220213478A1 (en) 2019-04-18 2022-07-07 Proqr Therapeutics Ii B.V. Antisense oligonucleotides for the treatment of usher syndrome
CN110090225B (zh) * 2019-04-19 2021-07-16 济南康和医药科技有限公司 一种依达拉奉氯化钠注射液及其制备方法
US20220290154A1 (en) 2019-08-08 2022-09-15 Stichting Radboud Universitair Medisch Centrum Antisense oligonucleotides rescue aberrant splicing of ABCA4
IT201900019190A1 (it) 2019-10-17 2021-04-17 Univ Politecnica Delle Marche Derivato dell’epigallocatechina gallato
WO2021175904A1 (en) 2020-03-04 2021-09-10 Proqr Therapeutics Ii B.V. Antisense oligonucleotides for use in the treatment of usher syndrome
WO2022090256A1 (en) 2020-10-26 2022-05-05 Proqr Therapeutics Ii B.V. Antisense oligonucleotides for the treatment of stargardt disease
EP4599061A1 (en) 2022-10-06 2025-08-13 Stichting Radboud universitair medisch centrum Antisense oligonucleotides for treatment of usher 2a. exon 68
EP4758249A1 (en) 2023-08-11 2026-06-17 Stichting Radboud universitair medisch centrum Antisense oligonucleotides for treatment of usher 2a. exon 53
WO2025186392A1 (en) 2024-03-06 2025-09-12 Stichting Radboud Universitair Medisch Centrum Therapeutics abca4 genome editing for treatment of stargardt disease
WO2026094043A1 (en) * 2024-10-31 2026-05-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Cns delivery of iron-chelators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1318539B1 (it) 2000-05-26 2003-08-27 Italfarmaco Spa Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente
US6417237B1 (en) * 2000-06-08 2002-07-09 The Board Of Trustees Of The University Of Illinois Macromolecular drug complexes and compositions containing the same
NZ535270A (en) * 2002-03-12 2006-11-30 Univ Montreal Composition having gelling properties for the sustained delivery of bioactive substances
EP1867323A1 (en) * 2006-06-13 2007-12-19 Farmatron Ltd. Pharmaceutical compositions with biological barriers permeation enhancing properties
US9125807B2 (en) 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
CA2701470A1 (en) 2007-10-02 2009-04-09 Potentia Pharmaceuticals, Inc. Sustained delivery of compstatin analogs from gels

Also Published As

Publication number Publication date
CY1114688T1 (el) 2016-10-05
EP2425814A1 (en) 2012-03-07
ES2426603T3 (es) 2013-10-24
UA111168C2 (uk) 2016-04-11
SI2425814T1 (sl) 2013-10-30
EP2425814B1 (en) 2013-06-19
HRP20130830T1 (en) 2013-10-11
SMT201300101B (it) 2013-11-08
PT2425814E (pt) 2013-09-02
DK2425814T3 (da) 2013-09-08

Similar Documents

Publication Publication Date Title
HRP20130830T1 (en) A water-in-oil type emulsion for treating a disease of the eye
ZA201203291B (en) Ophthalmic emulsion
HUE037660T2 (hu) Androgén készítmény szembetegség kezelésére
EP2790622A4 (en) LITHOTRITIC OCULAR TREATMENT
EP2760359A4 (en) METHOD FOR TREATING EYE STATES
EP2753275A4 (en) METHODS OF TREATING OCULAR CONDITIONS
IL260714B (en) Methods for the treatment and diagnosis of blinding eye diseases
PL2696839T3 (pl) Sposoby wytwarzania emulsji olej w wodzie
SG10201605500TA (en) Cationic oil-in-water emulsions
PT2723283T (pt) Aparelho para cirurgia aos olhos
PL2560616T3 (pl) Emulsja naśladująca łzy
PL2575881T3 (pl) Przeciwciała swoiste wobec CD160 do leczenia zaburzeń oczu związanych z angiogenezą
IL230960A0 (en) A device for the treatment of eye disease
ZA201108661B (en) Oil-in-water emulsion
PT2709577T (pt) Aparelho para a observação ou para o tratamento de um olho humano
PL2959903T3 (pl) Lek do leczenia chorób oczu
EP2662068A4 (en) OIL EMULSION COMPOSITION IN WATER
ZA201108660B (en) Oil-in-water emulsion
EP2692333A4 (en) COSMETICS WITH WATER IN OIL EMULSION
PL2923208T3 (pl) Sposoby określania ryzyka ostrej choroby przeszczep przeciwko gospodarzowi
IL230959B (en) A device for the treatment of eye disease
EP2915523A4 (en) Water-in-oil emulsion composition
PT2900066T (pt) Método e sistema para o aumento da eficácia biocida de sais de monoalquilditiodiocarbamatos
IL238363A0 (en) Methods for treating eye diseases
ZA201407215B (en) Method for emulsion treatment